
Enzalutamide 40mg Capsule
Salt Composition: Enzalutamide
Expiry Date: 01/2028
Inclusive of all taxes
28 Capsules
About The Product
Prostate Cancer
Enzalutamide 40mg Capsule belongs to the group of medicines known as antineoplastic endocrine therapies. The doctor prescribes this anticancer medicine in the treatment of prostate cancer. It works by blocking the effect of testosterone as it is a competitive androgen receptor inhibitor.
Side Effects
- Like any other anticancer medicine, Enzalutamide 40mg Capsule also shows some side effects, which vary from one person to another according to various health factors.
- Most of them are mild, and some are serious enough to need immediate medical attention.
- Some Common side effects include: Bleeding Sudden weight gain Painful urination Dry skin Nausea High blood pressure Irregular heartbeat Difficulty in breathing Blurred vision Low white blood cell count Bloating Joint pain Drowsiness Vomiting Hot flashes Skin rash Allergic reaction Pounding in the ears Contact a doctor immediately if you experience any unusual or serious side effects.
How To Use
- Dosage and duration of Enzalutamide 40mg Capsule are generally decided by the doctor according to the patient's health condition.
- This capsule should be swallowed as a whole with water and should not be crushed, chewed, or cut.
- Don't stop medication on your own without informing your doctor, as it can decrease the effectivness of the medicine.
Safety Advice
Missed Doses
- Initially, it is advisable to not miss a dose.
- However, if such a case happens, make sure to consult your healthcare provider to schedule an appointment for the same or guide you further.
FAQs
Enzalutamide 40mg capsule is an anti-cancer medication that is prescribed for the treatment of Prostate cancer.
It works by blocking the effect of testosterone.
Reference
1. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC6916586/
3. Lee, S. M., Lee, J. G., Yun, T. H., Cho, J. H., & Kim, K. S. (2024). Enhanced stability and improved oral absorption of enzalutamide with self-nanoemulsifying drug delivery system. International Journal of Molecular Sciences, 25(2), 1197.
4. Krauwinkel, W., Noukens, J., Van Dijk, J., Popa, S., Ouatas, T., De Vries, M., ... & Mateva, L. (2017). A comparison of the pharmacokinetics and safety of enzalutamide in subjects with hepatic impairment and matched healthy subjects. Journal of Clinical Pharmacy and Therapeutics, 42(3), 268-275.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
